Microbiology of sputum from patients at cystic fibrosis centers in the UNited States

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 158-163

  Burns, Jane L ^a   Emerson, Julia ^b   Stapp, Jenny R ^b   Yim, Darlene L ^b   Krzewinski, Jay ^b   Louden, Laurie ^b   Ramsey, Bonnie W ^b   Clausen, Carla R ^b  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN;

ALCALIGENES; ARTICLE; ASPERGILLUS; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; THROAT CULTURE; UNITED STATES;

EID: 0031874764     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514631     Document Type: Article

References (17)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Govan JRW, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992;48:912-30.
3. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
4. Cystic Fibrosis Foundation. Patient registry 1995 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, 1996:28-30.
5. Cystic Fibrosis Foundation. Patient registry 1996 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, 1997:31-3.
6. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041-9.
7. Govan JRW, Brown PH, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
8. Cystic Fibrosis Foundation. Microbiology and infectious disease in cystic fibrosis. Consensus Conference: Concepts in Care. Vol. 5, section 1. Bethesda, MD: Cystic Fibrosis Foundation, 1994.
9. Wong K, Roberts MC, Owens L, Fife M, Smith AL. Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol 1984;17:113-9.
10. Shigei J. Test methods used in the identification of commonly isolated aerobic gram-negative bacteria. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992:1.19.1-104.
11. National Committee for Clinical Laboratory Standards (NCCLS). Minimum inhibitory concentration (MIC) interpretive standards (pg/mL) for organisms other than Haemophilus spp., Neisseria gonorrhoeae, and streptococci. M7-A3. Villanova, PA: NCCLS, 1995:15.
12. Karpati F, Malmborg A-S, Alfredsson H, Hjelte L, Strandvik B. Bacterial colonisation with Xanthomonas maltophilia - a retrospective study in a cystic fibrosis patient population. Infection 1994;22:258-63.
13. Dunne WM Jr, Maisch S. Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction. Clin Infect Dis 1995;20:836-41.
14. Moissenet D, Baculard A, Valcin M, et al. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis 1997;24:274-5.
15. LiPuma J, Henry D, Mehar F, Speert D, Saiman L. Misidentification of Burkholderia cepacia. Pediatr Res 1997;41:304A.
16. Klinger JD, Thomassen MJ. Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis 1985;3:149-58.
17. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993;328:1740-6.